Threats, opportunities, and statins in the modern management of heart failure

被引：13

作者：

Cleland, JGF ^{[1
]}

Loh, H ^{[1
]}

Windram, J ^{[1
]}

Goode, K ^{[1
]}

Clark, AL ^{[1
]}

机构：

[1] Univ Hull, Castle Hill Hosp, Dept Cardiol, Kingston Upon Hull, Yorks, England

来源：

EUROPEAN HEART JOURNAL | 2006年 / 27卷 / 06期

关键词：

D O I：

10.1093/eurheartj/ehi812

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：641 / 643

页数：3

共 9 条

[1] Prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy [J].

Christ, M ;

Klima, T ;

Grimm, W ;

Mueller, HH ;

Maisch, B .

EUROPEAN HEART JOURNAL, 2006, 27 (06) :691-699

[2] Delivering the cumulative benefits of triple therapy to improve outcomes in heart failure - Too many cooks will spoil the broth [J].

Cleland, JGF ;

Clark, AL .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (07) :1234-1237

[3] The heart failure revascularisation trial (HEART): rationale, design and methodology [J].

Cleland, JGF ;

Freemantle, N ;

Ball, SG ;

Bonser, RS ;

Camici, P ;

Chattopadhyay, S ;

Dutka, D ;

Eastaugh, J ;

Hampton, J ;

Large, S ;

Norell, MS ;

Pennell, DJ ;

Pepper, J ;

Sanda, S ;

Senior, R ;

Smith, D .

EUROPEAN JOURNAL OF HEART FAILURE, 2003, 5 (03) :295-303

[4] Is aspirin "the weakest link" in cardiovascular prophylaxis? The surprising lack of evidence supporting the use of aspirin for cardiovascular disease [J].

Cleland, JGF .

PROGRESS IN CARDIOVASCULAR DISEASES, 2002, 44 (04) :275-292

[5]

Hofman-Bang C, 1995, J Card Fail, V1, P101, DOI 10.1016/1071-9164(95)90011-X

[6] A statin in the treatment of heart failure?: Controlled rosuvastatin multinational study in heart failure (CORONA):: Study design and baseline characteristics [J].

Kjekshus, J ;

Dunselman, P ;

Blideskog, M ;

Eskilson, C ;

Hjalmarson, Å ;

McMurray, JV ;

Waagstein, F ;

Wedel, H ;

Wessman, P ;

Wikstrand, J .

EUROPEAN JOURNAL OF HEART FAILURE, 2005, 7 (06) :1059-1069

[7] More 'malignant' than cancer? Five-year survival following a first admission for heart failure [J].

Stewart, S ;

MacIntyre, K ;

Hole, DJ ;

Capewell, S ;

McMurray, JJV .

EUROPEAN JOURNAL OF HEART FAILURE, 2001, 3 (03) :315-322

[8] The current cost of heart failure to the National Health Service in the UK [J].

Stewart, S ;

Jenkins, A ;

Buchan, S ;

McGuire, A ;

Capewell, S ;

McMurray, JJJV .

EUROPEAN JOURNAL OF HEART FAILURE, 2002, 4 (03) :361-371

[9] Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure [J].

Tavazzi, L ;

Tognoni, G ;

Franzosi, MG ;

Latini, R ;

Maggioni, AP ;

Marchioli, R ;

Nicolosi, GL ;

Porcu, M .

EUROPEAN JOURNAL OF HEART FAILURE, 2004, 6 (05) :635-641

← 1 →